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Staphylococcus aureus bacteremia (SAB) is associated with considerable morbidity 
mortality
1
. Mandatory Infectious Diseases (ID) consultation for SAB was introduced to 
the Lehigh Valley Health Network in order to improve the care of SAB patients at both 
the Cedar Crest and Muhlenberg campuses. This study sought to determine if mandatory 
ID consultation improves adherence to published guidelines on quality-of-care indicators 
and improves outcomes of patients with SAB. A retrospective study was conducted 
comparing 179 SAB patients from the pre-intervention period (January 2013 through 
December 2013), to 197 SAB patients from the intervention period (May 2014 through 
May 2015). Comparison of the pre-intervention and intervention group revealed that the 
incidence of ID consultation was similar between the two groups (98% vs 98%, p=NS); 
however, there was a significant improvement in appropriate duration of treatment (72% 
vs 91%, p=0.009), and appropriate antibiotic deescalation in patients with methicillin-
sensitive SAB (37% vs. 53%, p=0.012) between the pre-intervention and intervention 
groups.  The implementation of mandatory ID consultation resulted in improvement in 
the quality of care for SAB patients. Though the sample size was small and the duration 
of this study short, this quality improvement study is useful in examining the factors that 
lead to better patient care and aid in the advancement of standard-of-care protocols for 




Staphylococcus aureus bacteremia (SAB) is a major human pathogen that causes a wide-
range of clinical infections.
6
 It is a leading cause of bacteremia and infective endocarditis, 
as well osteoarticular, skin and soft tissue, and device-related infections.
6
 It is also one of 
the main contributors to both hospital and community-onset bloodstream infections 
worldwide.
5 
SAB continues to grow in number and complexity as a consequence of 
advances in patient care and the pathogen’s ability to adapt to a changing environment.
7 
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, and improved compliance with treatment standards-of-
care
4
. ID consultation has also been shown to improve adherence to six quality-of-care 
indicators (QCI): performance of follow-up blood cultures, performance of 
echocardiography, appropriate antibiotic choice, particularly de-escalation to a β-lactam 
in methicillin-sensitive SAB,  length of therapy, early source control (removal of infected 
intravenous catheters or drainage of abscess), and adjustment of vancomycin dosing
5
.   
 
Lehigh Valley Health Network instituted mandatory ID consultations for patients with 
SAB on May 12, 2014. The purpose of this quality improvement project was to evaluate 
the impact of ID consultation on the management and outcome in patients with SAB. 
 
Methods 
276 patients from Lehigh Valley Cedar Crest (CC) and Muhlenberg (MHC) campuses 
had positive S. aureus blood cultures and met the predefined study inclusion criteria.  
Patients were identified from ICD-9 codes indicating “methicillin-sensitive S. aureus 
(MSSA) septicemia” or “methicillin-resistant S.aureus (MRSA) septicemia.”  In addition, 
the microbiology laboratory provided a list of all positive S. aureus blood cultures during 
the study period to cross-reference so that every instance of SAB was reviewed for 
possible inclusion.   
 
The following patients were excluded from analysis: (1) less than eighteen years of age, 
(2) had polymicrobial bacteremia, (3) if they refused treatment, or (4) experienced death, 
transfer, or initiation of hospice care within 24 hours of positive S. aureus blood cultures. 
 
179 patients were identified from January 1
st
 2013 to December 31
st
 2013, prior to the 
institution of mandatory ID SAB consultation, and 197 patients were identified from May 
12, 2014 to May 11, 2015, the intervention period. During the intervention period, all 
positive blood culture reports for MSSA or MRSA were entered into the microbiology 
system with the notation “An Infectious Disease consult is indicated for patients 
identified with Staphylococcus aureus bacteremia.” Positive S. aureus blood cultures 
were faxed to the ID office for notification.  If no consult request was received from the 
patient’s primary physician within 24 hours of the positive blood culture, the ID specialist 
contacted the attending of record directly to request involvement in the patient’s care. 
 
The cohorts were evaluated using two databases that were constructed using Microsoft 
Access, one that captured pre-intervention patients and the other that captured 
intervention patients.  
 
The patients’ medical records were reviewed for demographic data, features of S. aureus 
bacteremia, details regarding treatment, and outcomes.  These categories were chosen and 
defined by a cohort of previous studies that have found these features to be either 
attributing factors to the development of S. aureus bacteremia or good evaluators of 
quality-of-care.
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The characteristics of patients with Staphylococcus aureus bacteremia were very similar 
between the two groups.  There was a notable exception of female-predominance in the 
pre-intervention group (46% vs 33%, p=0.007), and an increased the number of 
community-acquired infections in the intervention period (62% vs 45%, 0.003) (Table 1).  
 
Most of the particular features of S. aureus infection in the pre-intervention and 
intervention patients were similar (Table 2). However, there were significantly more 
endocarditis patients in the intervention period than there were during the pre-
intervention period (28% vs 21%, p=0.009). Data from prior studies suggest that infective 




ID consultation in the period prior to the introduction of mandatory SAB consultations 
was quite robust (98%) with little room for improvement.  Despite this, during the 
intervention period, there was a significant improvement in the duration of appropriate 
antibiotic duration (72% vs. 91%, p=0.009).  In addition, there was a significant 
improvement in appropriate deescalation to a β–lactam antibiotic in methicillin-sensitive 
SAB (37 vs. 53%, p=0.012) as well as improvement in the time to de-escalation in hours 
(64 vs 41, p=0.0001) .  Performance of echocardiography, another quality-of-care 
indicator showed a trend toward improved adherence (83% vs. 92%, p=0.126), with a 
significant increase in the number of transesophageal echocardiograms performed (37% 
vs. 56%, p=0.0026, Table 3).  
 
Interestingly, there was a significant difference between the amount of patients receiving 
follow up blood cultures 48-96 hours after a positive blood culture during the pre-
intervention period versus the intervention period (89% vs 77%, p=0.042, Table 3). This 
needs to be looked at more closely; as often, repeat blood cultures are taken within a 
more narrow time frame (24-48 hours) with improvements in early laboratory 
identification of the infecting organism. The quality-of-care indicator from the literature 
cites a specific time frame, likely as a refection of older techniques in which the 
Staphylococcus aureus organism is not identified as readily.  A future evaluation of the 
data will look for if repeat blood cultures were ever taken without the noted time 
constraint of 48-96 hours later.  
 
There was no significant difference in outcome measures between the two groups for 
hospital length of stay, attributable mortality (48% vs 66%, p=0.149) and 14-day and 30-
day mortality.  There was a significant difference in all-cause mortality between the two 




The incidence of ID consultation did not change during the pre-intervention and 
intervention periods.  Despite this, the program introducing mandatory ID consults did 
aid in improving adherence to quality-of-care indicators, particularly appropriate duration 
of antibiotics and appropriate and timely de-escalation of antibiotics in patients with 
methicillin-sensitive SAB. Even with the mandatory ID consultation protocol in place, 
four patients never received an ID consult (Table 3). This is likely secondary to human 
error as the microbiology laboratory technicians are responsible for faxing positive SAB 
blood cultures to the ID office for review.  In the future, an automatic facsimile will be 
sent whenever SAB is identified in order to improve the rate of ID consultation for SAB 
to 100%.   
 
There was a significant difference in the number of female patients between the two 
cohorts.   However, there is no literature to support an association of gender with 
Staphylococcus aureus bacteremia. This is most likely a confounding result from the 
study’s small data size, but it should be examined further in future analyses.   
 
All-cause mortality was significantly improved in the intervention group, however, that is 
most likely a reflection of the short duration of follow-up with patients from the 
intervention period. The intervention data collection ended May 11
th
, 2015 and thus 2 
months have lapsed since this period versus 19 months for the pre-intervention group.   
 
This study was a retrospective chart review to aid in the quality improvement of patients 
with SAB. It does have limitations that should be taken into account. This was a short 
duration, small, retrospective cohort study.  However, the introduction of a mandatory 
program is helpful to a hospital as large as Lehigh Valley Health Network as it aids to 
bring a more standardized method of care to patients on a much grander scale.  
 
In conclusion, this study’s results continues to add to the evidence that shows mandatory 
ID consultation improves clinical management, increases adherence to quality-of-care 
indicators, and potentially improves outcomes with patients who have Staphylococcus 
aureus bacteremia (SAB). A future challenge for the ID division is to continue improving 
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Table 1: Characteristics of Patients with Staphylococcus aureus Bacteremia 
Data presented as number of patients (%) unless otherwise specified. 
Abbreviations: COPD, chronic obstructive pulmonary disease; MRSA, methicillin-resistant S. aureus. 
±Congenital heart defects, artificial heart valves, implanted cardiac device, prior infective endocarditis, rheumatic 
fever, and intravenous drug abuse. 
¶Community-acquired: within 72 hours of admit in a patient without extensive healthcare contact,; healthcare-
associated: within 72 hours of extensive contact with healthcare system  (nursing home, organ transplantation, 
hemodialysis, presence of indwelling intravascular catheter, surgery within 30 days) ;hospital-acquired: >72 hours after 
hospitalization. 
 






Source of Infection 
      Intravascular catheter 
      Skin and soft tissue infection 
      Osteoarticular 
      Endocarditis 
      Other
⌘
 






















MRSA 75 (42) 70 (36) 0.286 
Fevers ≥72 hours after antibiotics 5 (3) 0 (0) 0.108 
Complicated Bacteremia§ 156 (87) 155 (79) 0.156 
Persistent Bacteremia° 6 (3) 3 (2) 0.760 
Recurrent Bacteremia 5 (3) 11 (6) 0.641 
Metastatic Infection 26 (15) 20 (10) 0.464 
Endocarditis 
   Definite 










Data presented as number of patients (%) unless otherwise specified. 
Abbreviations: MRSA, methicillin-resistant S. aureus. 
±Congenital heart defects, artificial heart valves, implanted cardiac device, prior infective endocarditis, rheumatic fever, IVDA 
⌘
Other, respiratory tract infection, endovascular infection other than catheter, urinary tract infection, central nervous system infection 
¶Community-acquired: within 72 hours of admit in a patient without extensive healthcare contact,; healthcare-associated: within 72 
hours of extensive contact with healthcare system  (nursing home, organ transplantation, hemodialysis, presence of indwelling 






Age, median years (IQR) 64 (54-78) 68 (52-76) 0.937 
Female 83 (46) 65 (33) 0.007 
White 152 (85) 180 (91) 0.404 
Comorbidities    
      At risk for endocarditis 44 (25) 62 (31) 0.160 
      COPD 19 (11) 22 (11) 0.927 
      Cardiovascular prosthesis 31 (17) 32 (16) 0.858 
      Diabetes mellitus 89 (50) 80 (40) 0.127 
      Dialysis 13 (7) 19 (10) 0.690 
      Immunosuppression 28 (16) 18 (9) 0.276 
      Malignancy 22 (12) 9 (5) 0.196 
      Orthopedic prosthesis 23 (13) 23 (12) 0.845 
      Trauma 14 (8) 20 (10) 0.691 
APACHE II Score, mean 13.4 13.5 0.995 




      Community-acquired 
      Healthcare-associated 













Penicillin allergy 28 (16) 28 (14) 0.811 
Table 3: Infectious Diseases (ID) Consultation and Adherence to Quality-of-Care Indicators 





ID Consult 176 (98) 193 (98) 0.953 
Days to ID consult, mean 0 (0-1) 0 (0-1) 0.072 
Follow-up blood cultures obtained 159 (89) 151 (77) 0.042 
Early source control
¶
 46 (82) 29 (85) 0.718 
Echocardiography performed 149 (83) 182 (92) .126 
         TTE 143 (80) 150 (76) .531 
         TEE 66 (37) 108 (56) 0.0026 
Treatment duration, median days 
(IQR) 
28 (14-42) 29 (19-42) 0.363 
Appropriate duration
§
 109 (72) 152 (91) 0.009 
Appropriate deescalation
±
 66 (37) 105 (53) 0.012 




64 (42-83) 41 (20-60) 0.0001 
Data presented as number of patients (%) unless otherwise specified 
Abbreviations: TTE=transthoracic echocardiogram; TEE= echocardiogram 
¶Removal of source of infection (nonpermanent vascular catheter, abscess drainage <72 hours, or hemodialysis graft); 56 patients in 
total requiring source removal for the pre-intervention period and 34 patients total for the intervention period 
±Applicable only to MSSA patients: de-escalation appropriate if within 24 hours of sensitivity results made available; beta lactams are 
better for MSSA patients than vancomycin, so if antibiotics are deescalated quicker from vancomycin to beta lactams in MSSA 
patients, they will have better outcomes 
°Time in hours from first antibiotic to de-escalation to B-lactam antibiotics when MSSA and non-allergic patient 
§In days, appropriate if patient on antibiotics ≥14 days for uncomplicated bacteremia, ≥28 days for complicated bacteremia, and ≥42 
days for endocarditis 
 






Length of hospitalization, median days (IQR) 12 (7-19) 13 (8-21) 0.329 
Attributable mortality° 28 (48) 25 (66) 0.149 
All-cause mortality 58 (32) 38 (19) 0.0281 
         14 days 18 (31) 16 (42) 0.295 
         30 days 8 (13) 8 (21) 0.510 
Data presented as number of patients (%) unless otherwise specified 
°58 patients died from the pre-intervention period and 38 patients died from the intervention period  
 
 
 
  
